As of 2026-05-18, the EV/EBITDA ratio of MacroGenics Inc (MGNX) is -3.41. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MGNX's latest enterprise value is 203.46 mil USD. MGNX's TTM EBITDA according to its financial statements is -59.61 mil USD. Dividing these 2 quantities gives us the above MGNX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 15.0x | 11.6x |
| Forward P/E multiples | 11.9x - 16.7x | 14.8x |
| Fair Price | (16.10) - (20.16) | (17.82) |
| Upside | -478.7% - -574.4% | -519.4% |
| Date | EV/EBITDA |
| 2026-05-15 | -3.41 |
| 2026-05-14 | -3.35 |
| 2026-05-13 | -2.81 |
| 2026-05-12 | -2.86 |
| 2026-05-11 | -2.43 |
| 2026-05-08 | -2.47 |
| 2026-05-07 | -2.43 |
| 2026-05-06 | -2.48 |
| 2026-05-05 | -2.59 |
| 2026-05-04 | -2.62 |
| 2026-05-01 | -2.57 |
| 2026-04-30 | -2.53 |
| 2026-04-29 | -2.43 |
| 2026-04-28 | -2.48 |
| 2026-04-27 | -2.51 |
| 2026-04-24 | -2.62 |
| 2026-04-23 | -2.61 |
| 2026-04-22 | -2.79 |
| 2026-04-21 | -2.83 |
| 2026-04-20 | -2.83 |
| 2026-04-17 | -2.82 |
| 2026-04-16 | -2.78 |
| 2026-04-15 | -2.86 |
| 2026-04-14 | -2.84 |
| 2026-04-13 | -2.83 |
| 2026-04-10 | -2.92 |
| 2026-04-09 | -2.80 |
| 2026-04-08 | -2.81 |
| 2026-04-07 | -2.74 |
| 2026-04-06 | -2.61 |
| 2026-04-02 | -2.52 |
| 2026-04-01 | -2.40 |
| 2026-03-31 | -2.39 |
| 2026-03-30 | -2.29 |
| 2026-03-27 | -2.42 |
| 2026-03-26 | -2.61 |
| 2026-03-25 | -2.60 |
| 2026-03-24 | -2.27 |
| 2026-03-23 | -2.41 |
| 2026-03-20 | -2.37 |
| 2026-03-19 | -2.40 |
| 2026-03-18 | -2.46 |
| 2026-03-17 | -2.53 |
| 2026-03-16 | -2.55 |
| 2026-03-13 | -2.47 |
| 2026-03-12 | -2.56 |
| 2026-03-11 | -2.73 |
| 2026-03-10 | -2.80 |
| 2026-03-09 | -1.99 |
| 2026-03-06 | -1.89 |